Envista Holdings (NVST) Cash from Financing Activities (2018 - 2026)

Envista Holdings (NVST) recorded quarterly Cash from Financing Activities of -$45.6 million in Q2 2026, down 80.95% quarter-over-quarter from -$25.2 million in Q4 2025, and down 159.09% on a YoY basis from $77.2 million in Q2 2025.

Envista Holdings (NVST) Cash from Financing Activities (2018 - 2026) Analysis & Trends

Envista Holdings' Cash from Financing Activities history runs 9 years deep, the most recent figure standing at -$45.6 million for Q2 2026.

  • In Q2 2026, Cash from Financing Activities fell 159.09% year-over-year to -$45.6 million; the TTM figure through Apr 2026 stood at -$198.9 million (down 67.57% YoY), while the FY2025 annual figure was -$170.9 million, down 64.8% from the prior year.
  • Cash from Financing Activities was -$45.6 million for Q2 2026 at Envista Holdings, down from -$25.2 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $114.5 million in Q3 2023 to a low of -$100.5 million in Q3 2024.
  • Historically, Cash from Financing Activities has averaged -$11.1 million across 5 years, with a median of -$1.5 million in 2023.
  • The sharpest annual moves came in 2022 and 2025: Cash from Financing Activities jumped 1813.95% in 2022, then sank 28900.0% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at -$68.3 million in 2022, then surged by 104.83% to $3.3 million in 2023, then slumped by 127.27% to -$900000.0 in 2024, then tumbled by 2700.0% to -$25.2 million in 2025, then slumped by 80.95% to -$45.6 million in 2026.
  • The last three Cash from Financing Activities figures came in at -$45.6 million (Q2 2026), -$25.2 million (Q4 2025), and -$41.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn -1.35 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -414.00 Mn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn -13.00 Mn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn -255.24 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn -308.70 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn -50.00 Mn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -75.80 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn -48.13 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn -11.00 Mn
10 Envista Holdings 4.06 Bn 2.98 Bn 390.10 Mn -45.60 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 -45.60 Mn
Apr 3, 2026 -45.60 Mn
Dec 31, 2025 -25.20 Mn
Dec 31, 2025 -25.20 Mn
Sep 26, 2025 -41.70 Mn
Sep 26, 2025 -41.70 Mn
Jun 27, 2025 -86.40 Mn
Jun 27, 2025 -86.40 Mn
Mar 28, 2025 -17.60 Mn
Mar 28, 2025 -17.60 Mn
Dec 31, 2024 -900,000.00
Dec 31, 2024 -900,000.00
Sep 27, 2024 -100.50 Mn
Sep 27, 2024 -100.50 Mn
Jun 28, 2024 300,000.00
Jun 28, 2024 300,000.00
Mar 29, 2024 -2.60 Mn
Mar 29, 2024 -2.60 Mn
Dec 31, 2023 3.30 Mn
Dec 31, 2023 3.30 Mn